These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2658822)

  • 1. [Studies of second-look operations (SLO) in ovarian cancer].
    Yuzawa H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1310-6. PubMed ID: 2658822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reassessment of second-look operations (SLO) in the treatment of ovarian cancer].
    Ochiai K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1303-9. PubMed ID: 2730043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer].
    Ohta M; Tomoda Y; Kano T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer.
    Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A
    Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment and prognostic factors of epithelial ovarian cancer].
    Wei L; Qian H; Li W
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):476-9. PubMed ID: 9639741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of second look surgery in the therapy of ovarian cancer].
    Sasaki H; Ochiai K; Terashima Y
    Gan No Rinsho; 1990 Aug; 36(10):1174-8. PubMed ID: 2214157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
    Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
    Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current therapeutic approaches to advanced ovarian cancer.
    Nishimura H; Hamaguchi K; Miyahara K; Tazaki T; Tateno N; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1691-6. PubMed ID: 2277209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term clinical course after second laparotomy in ovarian cancer].
    Stöckle E; Chauvergne J; Pigneux J; Avril A; Bussières E; Thomas L; Chevalier M; Marée D
    Bull Cancer; 1990; 77(11):1087-98. PubMed ID: 2275986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage III-IV epithelial carcinoma of the ovary: is the second-look operation of any value for the patient?
    Atad J; Bornstein J; Steiner M; Weill S; Lurie M; Abramovici H
    Isr J Med Sci; 1988 Nov; 24(11):660-3. PubMed ID: 3215758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategy in the management of stage II-IV epithelial ovarian carcinoma.
    Sun T; Feng Y; Zhu Y; Zheng Y
    Chin Med J (Engl); 2000 Jul; 113(7):625-7. PubMed ID: 11776033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrent epithelial ovarian cancer].
    Ding X; Lang J; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):30-2. PubMed ID: 11263170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of second cytoreductive surgery in the treatment of epithelial ovarian cancer.
    Sun T; Feng Y
    Chin Med J (Engl); 1998 Mar; 111(3):272-4. PubMed ID: 10374433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer].
    Li M; Huang X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):621-3. PubMed ID: 9275460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy and surgical procedure in the management of ovarian malignancies. Evaluation of second look operations].
    Yakushiji M; Nishimura H
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1664-70. PubMed ID: 3592708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.